SOPHiA GENETICS SA Hits New 52-Week High at USD 6.28

SOPHiA GENETICS SA has reached a significant milestone by hitting a new 52-week high of USD 6.28 on June 30, 2026. This achievement marks a notable increase from its 52-week low of USD 2.81, reflecting a year-over-year performance of 20.21%. In comparison, the S&P 500 has shown a slightly higher performance of 20.86% during the same period. As a microcap company in the software products industry, SOPHiA GENETICS SA has a market capitalization of USD 337 million. The company currently does not offer a dividend, and its financial metrics indicate a challenging landscape, with a negative return on equity of -159.46% and a debt-to-equity ratio of -0.42. The price-to-book ratio stands at 7.14, suggesting that the stock is trading at a premium relative to its book value. This recent price movement highlights the stock's volatility and the dynamic nature of the software products sector, as SOPHiA GENETICS SA continues to navigate its market position.